Stay updated on Pembrolizumab Effects in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Effects in Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page no longer displays a 403 Forbidden error and instead shows the ClinicalTrials.gov site shell with an NIH notice about its terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    2%
    Check dated 2026-10-24T16:09:10.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.
    Difference
    0.3%
    Check dated 2026-10-17T16:07:15.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:59:22.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and navigation, and a large set of study-related terms appears to have been removed, indicating an access issue rather than an update to core study details.
    Difference
    19%
    Check dated 2026-09-19T18:37:03.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The site revision was updated to v3.6.6, indicating a platform-level update. This change does not alter the study content or user-facing details on the NCT02644369 page.
    Difference
    0.1%
    Check dated 2026-08-29T18:58:06.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    A broad set of disease-related MeSH terms and categories were added to the study record, expanding the indexed topics (e.g., Melanoma, Ovarian Neoplasms, Triple Negative Breast Neoplasms, etc.). This broadens how the study can be found and linked to related conditions and terminologies.
    Difference
    50%
    Check dated 2026-08-15T13:48:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Effects in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.